A flagship cannabis exchange-traded fund (ETF) revealed its latest quarterly changes this week, including the removal of seven stocks from its index.

Meanwhile, a cannabis investment company made official the announcement of a new CEO and board member as it tries to resolve a disagreement with a core group of shareholders.

Keep reading to find out more cannabis highlights from the past five days.

Cannabis ETF cuts seven stocks

Horizons ETFs Management (Canada) announced this week the most recent rebalancing of its two cannabis ETFs, the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) and the Horizons US Marijuana Index ETF (NEO:HMUS).

According to Horizons ETFs, securities in the HMMJ index should have market capitalizations of over C$75 million. President and CEO Steve Hawkins said he’s seen momentum shift from Canada-based names to the US side of the market with the performance of multi-state operators below the border.

“Despite a strong recovery in Q2 2020 following the market volatility in March, Canada’s marijuana industry struggled in the third quarter in the face of COVID-19’s continued pressure on businesses and a lack of positive news to buoy the sector,” Hawkins said.

Amid these changes, seven cannabis stocks were demoted from the HMMJ index:

  • Agraflora Organics International (CSE:AGRA,OTC Pink:AGFAF)
  • The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF)
  • Khiron Life Sciences (TSXV:KHRN,OTCQX:KHRNF)
  • Namaste Technologies (TSXV:N,OTCQB:NXTTF)
  • Pharmacielo (TSXV:PCLO,OTCQX:PCLOF)
  • Sundial Growers (NASDAQ:SNDL)

Investment company appoints new CEO as it faces dispute

Australis Capital (CSE:AUSA,OTCQB:AUSAF), an investment arm spinoff of Aurora Cannabis (NYSE:ACB,TSX:ACB), is facing a standoff with a group of disgruntled shareholders who are asking the company meet its demands regarding changes in leadership.

After various back-and-forth statements, Australis has now told the market it has made Harry DeMott, former founding investor of Columbia Care (NEO:CCHW,OTCQX:CCHWF), its new CEO.

“Having witnessed the opportunities firsthand as an investor and operator in the space, I truly believe that the time to invest in and build branded cannabis assets is now,” DeMott said in a statement.

Back in August, the investors issued a statement demanding the company made changes given what they called mismanagement regarding a missed acquisition deal by Australis.

Eventually, the company held a meeting with the investors who wanted the changes. However, the meeting failed to create a resolution as both parties claimed bad faith from one another in the gathering.

Alongside the new executive is the appointment of Rick Cutler as an independent member of the Australis board of directors. Cutler comes in as the company confirmed the resignation of John Dover from its board. Earlier this year, the company also saw its former CFO Michael Carlotti depart.

“Having known Rick for well over a decade, I feel confident that he adds a level of experience with branded products that is unmatched at AUSA, and that he will be a valuable addition to the team,” DeMott added in the release.

Cannabis company news

  • Inner Spirit Holdings (CSE:ISH) opened two new stores in the provinces of Ontario and Newfoundland and Labrador, boosting its total of Spiritleaf-branded stores to 60 in the country.
  • Aphria (NASDAQ:APHA,TSX:APHA) confirmed the first delivery of an unspecified medical cannabis shipment from its facility to its German distributor subsidiary, CC Pharma.
  • TerrAscend (CSE:TER,OTCQX:TRSSF) told investors it has launched sales from the new San Francisco cultivation facility of its investee company, State Flower.
  • Neptune Wellness Solutions (NASDAQ:NEPT,TSX:NEPT) gave its shareholders an extensive update on its business amid the global COVID-19 pandemic.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press releases dated July 21, 2020 and July 31, 2020, the Company proposes to amend the exercise price of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

The Company had initially proposed a lower amended price, but that proposal was not approved by the TSX Venture Exchange (“Exchange“), however, the Exchange indicated that a $0.10 exercise price, may be more acceptable. Accordingly, the proposed amendment remains subject to Exchange approval.

Keep reading... Show less

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce that it has engaged VisionWorks Engineering of San Diego, CA to commence engineering work to complete and test a proof of concept prototype of its nasal mist device.

This is a major milestone towards the ultimate goal for development of effective delivery methods and commercialization. The Company holds several provisional patent applications including for a nasal mist device entitled “Device and Method for the Treatment of Traumatic Brain Injuries and Post-Traumatic Stress Disorder”. This device includes a nasal delivery system for administration of pharmaceutical agents such as a psilocybin-derived agent and/or N-acetylcysteine (“NAC“) at preselected dosages and times. The device design allows for the precise control and delivery of medicines through the nasal cavity for faster and more efficient uptake of psychedelics and other medicines that target the brain.

Keep reading... Show less

Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave“, “NGW” or the “Company”) is pleased to confirm the appointment of Ben Kovacs to the Company’s Board of Directors.

Mr. Kovacs was the former Chief Revenue Officer at NorCal Cannabis, one of the largest vertically integrated indoor producers in California. Mr. Kovacs is also the Chairman of a group of companies in the cannabis hardware space; this includes the international Octave & Myster brands.

Keep reading... Show less